Topic: Health

Scientists at the University of Missouri created a special antibody that lights up cancer tumors in medical scans. This helps doctors find out which patients will benefit from targeted treatments.

Researchers at the University of Missouri are developing a new way to detect cancer. They have designed an antibody called 'Flashlight' that finds a protein called EphA2, often found in cancer tumors. The Flashlight has a radioactive marker that makes it visible during a PET scan.

The scientists tested the Flashlight on mice and found that it clearly showed up tumors that had EphA2. This means doctors can use the Flashlight to detect cancers with this protein and decide which patients will benefit from targeted treatments.

Currently, doctors rely on biopsies and MRI scans to evaluate tumors. These methods can be invasive and take a long time. The new method is non-invasive and gives results in hours, making it much faster and easier for both patients and doctors.

Why It Matters

This technology could help Indian cancer patients get the right treatment quickly and easily. It's an important step towards precision medicine, which can save lives and reduce healthcare costs.

Key Facts

• Scientists at the University of Missouri created a special antibody called 'Flashlight' that lights up cancer tumors in medical scans.
• The Flashlight finds a protein called EphA2, often found in cancer tumors.
• The new method is non-invasive and gives results in hours, making it much faster and easier for both patients and doctors.
• Doctors currently rely on biopsies and MRI scans to evaluate tumors, which can be invasive and take a long time.
• The study was published in the journal Molecular Imaging and Biology.

Key Terms

EphA2

A protein often found in cancer tumors

Implications

This technology could help Indian cancer patients get the right treatment quickly and easily. It's an important step towards precision medicine, which can save lives and reduce healthcare costs.